E V Oaks
Overview
Explore the profile of E V Oaks including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
1062
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaminski R, Wu M, Turbyfill K, Clarkson K, Tai B, Bourgeois A, et al.
Clin Vaccine Immunol
. 2014 Jan;
21(3):366-82.
PMID: 24403527
Studies were undertaken to manufacture a multivalent Shigella inactivated whole-cell vaccine that is safe, effective, and inexpensive. By using several formalin concentrations, temperatures, and incubation periods, an optimized set of...
2.
Turbyfill K, Hartman A, Oaks E
Infect Immun
. 2000 Nov;
68(12):6624-32.
PMID: 11083774
The invasiveness and virulence of Shigella spp. are largely due to the expression of plasmid-encoded virulence factors, among which are the invasion plasmid antigens (Ipa proteins). After infection, the host...
3.
Coster T, Hoge C, VanDeVerg L, Hartman A, Oaks E, Venkatesan M, et al.
Infect Immun
. 1999 Jun;
67(7):3437-43.
PMID: 10377124
The Shigella flexneri 2a SC602 vaccine candidate carries deletions of the plasmid-borne virulence gene icsA (mediating intra- and intercellular spread) and the chromosomal locus iuc (encoding aerobactin) (S. Barzu, A....
4.
Turbyfill K, Mertz J, Mallett C, Oaks E
Infect Immun
. 1998 May;
66(5):1999-2006.
PMID: 9573082
Transport and surface expression of the invasion plasmid antigens (Ipa proteins) is an essential trait in the pathogenicity of Shigella spp. In addition to the type III protein secretion system...
5.
Alexander W, Hartman A, Oaks E, Venkatesan M
Vaccine
. 1996 Aug;
14(11):1053-61.
PMID: 8879102
Human challenge studies with EcSf2a-2, an aroD deletion-attenuated Escherichia coli K12-Shigella flexneri hybrid vaccine expressing S. flexneri 2a somatic antigen and the invasive phenotype indicated that, at doses of 2...
6.
Oaks E, Picking W, Picking W
Clin Diagn Lab Immunol
. 1996 Mar;
3(2):242-5.
PMID: 8991646
The antigen preparation most often used for determining the levels of antibodies to virulence-associated proteins of Shigella spp. consists of a mixture of proteins (including IpaB, IpaC, IpaD, and VirG*)...
7.
Turbyfill K, Joseph S, Oaks E
Infect Immun
. 1995 Oct;
63(10):3927-35.
PMID: 7558301
The invasive ability of Shigella spp. is correlated with the expression of several plasmid-encoded proteins, including invasion plasmid antigen C (IpaC). By characterizing the antigenic structure of IpaC with monoclonal...
8.
Hickman C, Stover C, Joseph S, Oaks E
Infect Immun
. 1993 May;
61(5):1674-81.
PMID: 8478055
A polyclonal T-cell line with TH1 characteristics was used to assess the murine cellular immune response to native and recombinant Rickettsia tsutsugamushi antigens. Proliferation of this T-cell line was observed...
9.
Venkatesan M, Buysse J, Oaks E
J Bacteriol
. 1992 Mar;
174(6):1990-2001.
PMID: 1312536
An avirulent, invasion plasmid insertion mutant of Shigella flexneri 5 (pHS1059) was restored to the virulence phenotype by transformation with a partial HindIII library of the wild-type invasion plasmid constructed...
10.
Oaks E, Turbyfill K
Infect Immun
. 1992 Feb;
60(2):557-64.
PMID: 1370431
IpaB, invasion plasmid antigen B, of Shigella flexneri is a 62-kDa protein required for invasion of intestinal epithelial cells. IpaB is also one of several major protein antigens recognized by...